ROSENWALD LINDSAY A MD has filed 19 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 475424 shares of Fortress Biotech, Inc. ($FBIO) on March 18, 2026.
Activity breakdown: 11 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A | Common stock, par value $0.001 | 475424 | $0.00 | 4,586,841.0000 | 33,100,961 | 11.56% | 1.44% |
| Aug. 5, 2025 | Journey Medical Corp | $DERM | ROSENWALD LINDSAY A MD | Director | A | Common Stock, $0.0001 par value | 50000 | $0.00 | 387,616.0000 | 23,290,806 | 14.81% | 0.21% |
| June 25, 2025 | Journey Medical Corp | $DERM | ROSENWALD LINDSAY A MD | Director | A | Common Stock, $0.0001 par value | 7173 | $0.00 | 337,616.0000 | 22,611,040 | 2.17% | 0.03% |
| Jan. 1, 2025 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | A | Common stock, par value $0.001 | 454153 | $0.00 | 4,111,417.0000 | 20,784,334 | 12.42% | 2.19% |
| Sept. 23, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P | Warrants to Purchase Common Stock | 763359 | $0.13 | 763,359.0000 | 18,316,874 | 9999.99% | 4.17% |
| Sept. 23, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | ROSENWALD LINDSAY A MD | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| Sept. 23, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | P | Common stock, par value $0.001 | 763359 | $1.84 | 3,657,264.0000 | 18,316,874 | 26.38% | 4.17% |
| July 11, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5000 | $7.48 | 127,500.0000 | 18,316,874 | 4.08% | 0.03% |
| July 9, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5000 | $7.39 | 122,500.0000 | 18,316,874 | 4.26% | 0.03% |
| July 8, 2024 | Journey Medical Corp | $DERM | ROSENWALD LINDSAY A MD | Director | A | Common Stock, $0.0001 par value | 9728 | $0.00 | 330,443.0000 | 19,993,858 | 3.03% | 0.05% |
| July 8, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | 5000 | $7.35 | 117,500.0000 | 18,316,874 | 4.44% | 0.03% |
| June 28, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | COMMON STOCK, PAR VALUE $0.001 | 20000 | $1.64 | 2,893,905.0000 | 17,151,945 | 0.70% | 0.12% |
| May 16, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | COMMON STOCK, PAR VALUE $0.001 | 10000 | $1.76 | 2,873,905.0000 | 17,151,945 | 0.35% | 0.06% |
| March 25, 2024 | Journey Medical Corp | $DERM | ROSENWALD LINDSAY A MD | Director | P | Common Stock, $0.0001 par value | 10000 | $3.04 | 320,715.0000 | 18,232,422 | 3.22% | 0.05% |
| March 22, 2024 | Journey Medical Corp | $DERM | ROSENWALD LINDSAY A MD | Director | P | Common Stock, $0.0001 par value | 20000 | $3.40 | 310,715.0000 | 18,232,422 | 6.88% | 0.11% |
| Jan. 5, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | P | COMMON STOCK, PAR VALUE $0.001 | 50000 | $2.38 | 2,863,905.0000 | 8,110,906 | 1.78% | 0.62% |
| Jan. 1, 2024 | Fortress Biotech, Inc. | $FBIO | ROSENWALD LINDSAY A MD | President, CEO & Chairman | A | COMMON STOCK, PAR VALUE $0.001 | 216465 | $0.00 | 2,813,905.0000 | 8,110,906 | 8.33% | 2.67% |
| Sept. 8, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | ROSENWALD LINDSAY A MD | Director | P | Common Stock | 348675 | $0.72 | 354,318.0000 | 0 | 6178.89% | 0.00% |
| June 30, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | ROSENWALD LINDSAY A MD | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |